| Literature DB >> 25375882 |
Mel Campbell1, Hsing-Jien Kung2, Yoshihiro Izumiya3.
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8) is a γ-herpesvirus linked to Kaposi's sarcoma (KS) and two lymphoproliferative disorders, primary effusion lymphoma (PEL or body-cavity B-lymphoma [BCBL]) and a subset of Multicentric Castleman's Disease. During lytic growth, pervasive viral transcription generating a variety of transcripts with uncertain protein-coding potential has been described on a genome-wide scale in β- and γ-herpesviruses. One class of such RNAs is called long non-coding RNAs (lncRNAs). KSHV encodes a viral lncRNA known as polyadenylated nuclear RNA (PAN RNA), a copious early gene product. PAN RNA has been implicated in KSHV gene expression, replication, and immune modulation. PAN RNA expression is required for optimal expression of the entire KSHV lytic gene expression program. Latent KSHV episomes are coated with viral latency-associated nuclear antigen (LANA). LANA rapidly dissociates from episomes during reactivation. Here we review recent studies suggesting that PAN RNA may function as a viral lncRNA, including a role in the facilitation of LANA-episomal dissociation during lytic replication.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25375882 PMCID: PMC4246214 DOI: 10.3390/v6114165
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Mechanisms of lncRNA action.
| Name of lncRNA | Nature of lncRNA/Mode of Action | Consequence of the Regulation | Reference |
|---|---|---|---|
| ANRIL, HOTAIR, XIST, H19, KCNQ1OT1 | Scaffold molecule/Histone modification | Epigenetic gene silencing | [ |
| NEAT1 | Scaffold molecule/Protein assembly | Paraspeckles formation | [ |
| MALAT1 | Modifier of alternative splicing/Relocation of splicing factor | Modulation of alternative splicing | [ |
| BACE1AS | Regulation of mRNA stability/Modification of mRNA stability | Increased translation of BACE1 | [ |
| Pseudo-NOS | Translational control/Displacement of ribosome | Repressed translation of nNOS | [ |
| GAS5 | Decoy for DNA binding/Inhibition of DNA binding | Repressed GR mediated gene activation | [ |
Figure 1Working model of KSHV PAN lncRNA action. (A) Decoy. Expression of PAN RNA sequesters LANA (left) and chromatin modifying complexes such as PRC2 (right) from the KSHV genome that reduces or prevents H3K27me3 mark deposition [1]. (B) Guide/Scaffold. PAN RNA aids in the targeting of regulatory factor complexes to specific loci of viral or cellular genes, which regulate gene expression to suit viral needs requiring (a) activation (i.e., ORF50 locus during reactivation) (b) repression (i.e., cellular response to viral infection or reactivation [23,43,44]. Mechanisms of PAN RNA targeting to specific loci is currently unknown. Not shown is the potential for PAN RNA to act in cis as a lncRNA signal [1]. Large curved green arrows indicate complex eviction (upward arrow) or deposition (downward arrow) from a genomic locus. Histones are depicted as cylinders with histone tails emanating, (red tail, activation; blue tail, repression) K27 (demethylated histone H3K27) and K27me3 (histone H3K27 tri-methylated; repressive mark); K4 (histone H3K4, substrate for methylation, activating mark).